The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRDL.L Regulatory News (RDL)

  • There is currently no data for RDL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Net Asset Value(s)

12 May 2017 07:00

RNS Number : 9387E
Ranger Direct Lending Fund PLC
11 May 2017
 

RANGER DIRECT LENDING FUND PLC ("RANGER")

 

MONTHLY NET ASSET VALUE PER SHARE AND DIVIDEND UPDATE

 

The net asset value per share ("NAV") of the Ordinary Shares in the Company (ISIN GB00BW4NPD65) as at the close of business on 31 March 2017 was:

 

 

cum-income* basis was US $15.07 (Sterling equivalent amount being £12.00)

 

ex-income** basis was US $14.75 (Sterling equivalent amount being £11.75)

 

MTD Performance - NAV*** 0.74%

 

YTD Performance -NAV*** 2.28%

 

 

The Company currently expects to declare an interim dividend of USD 34.33 cents (GBP 26.51 pence based on an exchange rate of US$1.295:£1.00 which may differ from the exchange rate at the time the dividend is actually declared) per Ordinary Share following the Company's annual general meeting on 15 June 2017. This dividend is in respect of income and interest received from the portfolio in the first quarter of 2017.

Due to the qualified opinion on the financial statements of the Company for the year ended 31 December 2016, in accordance with the applicable Companies Act requirements, the dividend is proposed to be declared following the annual general meeting ("AGM") on 15 June 2017.

The Company also notes that it intends to renew its buyback authorities at its upcoming AGM and, until such time, it is restricted from buying back shares due to the qualification in its account.

This NAV has been calculated by Sanne Fiduciary Services Limited. The corresponding March newsletter is expected to be released on Monday 15 May.

 

*Cum-income NAV includes all current year income, less the value of any dividends paid in respect of the period together with the value of any dividends which have been declared and marked ex-dividend but not yet paid.

 

**Ex-income NAV is the Cum-income NAV excluding net current year income (net current year income being all current year income, less the value of any dividends paid in respect of the period together with the value of any dividends which have been declared and marked ex-dividend but not yet paid). Any undistributed income from the prior year is moved to retained earnings on the first business day of the new period, meaning that an ex-income NAV released during a financial year equates to the cum-income NAV less year to date undistributed income.

 

*** For reference, the February NAV per share, after the restatement due to the Princeton impairment, was £12.02 GBP ($14.93 USD), versus the originally stated NAV per share of £12.44 GBP ($15.45 USD).

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NAVUAOARBKAVAUR
Date   Source Headline
25th Jan 202111:50 amRNSPortfolio Update
12th Jan 20211:12 pmRNSResult of General Meeting
23rd Dec 20207:00 amRNSPortfolio Update
21st Dec 20204:59 pmRNSPublication of Delisting Circular and Notice of GM
21st Dec 20204:59 pmRNSHolding(s) in Company
10th Dec 20205:20 pmRNSDividend Declaration
27th Nov 20205:37 pmRNSHolding(s) in Company
25th Nov 20207:00 amRNSChange of AIFM and intention to delist
24th Nov 202010:31 amRNSPortfolio Update
26th Oct 20209:56 amRNSPortfolio Update
23rd Oct 20204:41 pmRNSSecond Price Monitoring Extn
23rd Oct 20204:36 pmRNSPrice Monitoring Extension
12th Oct 20207:00 amRNSPortfolio Update
22nd Sep 20207:00 amRNSHalf-year Report
16th Sep 20204:34 pmRNSDirector Declaration
9th Sep 202012:31 pmRNSPortfolio Update
20th Aug 202012:07 pmRNSSecond Price Monitoring Extn
20th Aug 202012:02 pmRNSPrice Monitoring Extension
22nd Jul 20209:43 amRNSPortfolio Update
9th Jul 202011:16 amRNSDirector Declaration
30th Jun 20203:37 pmRNSResult of AGM
24th Jun 20202:48 pmRNSPortfolio Update
8th Jun 20204:41 pmRNSSecond Price Monitoring Extn
8th Jun 20204:35 pmRNSPrice Monitoring Extension
4th Jun 20207:00 amRNSAnnual Financial Report
28th May 20206:00 pmRNSRevised Publication Date For The Annual Report
15th May 20204:40 pmRNSSecond Price Monitoring Extn
15th May 20204:35 pmRNSPrice Monitoring Extension
4th May 202011:21 amRNSPortfolio Update
30th Apr 20202:41 pmRNSPublication Date for Annual Report
27th Apr 20209:58 amRNSDisclosure of Rights Attaching to Equity Shares
7th Apr 20207:00 amRNSDividend Declaration
2nd Apr 202010:54 amRNSResignation of Director
30th Mar 20202:02 pmRNSPortfolio Update
16th Mar 20207:00 amRNSPrinceton Update
11th Mar 20207:00 amRNSPortfolio Update
20th Feb 20205:06 pmRNSPrinceton Update
3rd Feb 20207:00 amRNSPortfolio Update
17th Jan 20209:44 amRNSHolding(s) in Company
10th Jan 20204:41 pmRNSPrinceton Update
9th Jan 202012:11 pmRNSDividend Declaration
31st Dec 201911:18 amRNSUpdate - Standstill Agreement
24th Dec 201910:11 amRNSHolding(s) in Company
23rd Dec 20194:49 pmRNSPortfolio Update
10th Dec 201910:12 amRNSDirector Declaration
26th Nov 201911:29 amRNSPortfolio Update
26th Nov 20197:00 amRNSDividend Declaration
6th Nov 201910:07 amRNSPortfolio Update
28th Oct 20194:50 pmRNSDirector Declaration
24th Oct 201911:21 amRNSPortfolio Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.